Portside Wealth Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550K Sell
1,532
-108
-7% -$33K 0.06% 284
2026
Q1
$411K Sell
1,640
-365
-18% -$90.8K 0.06% 297
2025
Q4
$552K Sell
2,005
-530
-21% -$145K 0.07% 234
2025
Q3
$665K Buy
2,535
+22
+0.9% +$5.35K 0.09% 218
2025
Q2
$550K Sell
2,513
-785
-24% -$168K 0.08% 230
2025
Q1
$738K Buy
3,298
+203
+7% +$55.9K 0.12% 188
2024
Q4
$1.01M Buy
3,095
+76
+3% +$23.9K 0.17% 131
2024
Q3
$906K Buy
3,019
+204
+7% +$62.5K 0.15% 149
2024
Q2
$927K Sell
2,815
-118
-4% -$41.7K 0.18% 130
2024
Q1
$1.16M Buy
2,933
+258
+10% +$95.4K 0.21% 116
2023
Q4
$942K Buy
2,675
+33
+1% +$11.7K 0.18% 130
2023
Q3
$994K Sell
2,642
-55
-2% -$21.3K 0.19% 117
2023
Q2
$1.03M Buy
+2,697
New +$963K 0.19% 121

Other funds holding WST